nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Correction to Lancet Diabetes Endocrinol 2016; published online April 12. http://dx.doi.org/10.1016/S2213-8587(16)00036-X
|
|
|
2017 |
5 |
4 |
p. e2- 1 p. |
artikel |
2 |
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study
|
Bally, Lia |
|
2017 |
5 |
4 |
p. 261-270 10 p. |
artikel |
3 |
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
|
Sorli, Christopher |
|
2017 |
5 |
4 |
p. 251-260 10 p. |
artikel |
4 |
Extensive yellowish plaques over eyelids
|
Tan, Cheng |
|
2017 |
5 |
4 |
p. 312- 1 p. |
artikel |
5 |
Levothyroxine overuse: time for an about face?
|
Rodriguez-Gutierrez, Rene |
|
2017 |
5 |
4 |
p. 246-248 3 p. |
artikel |
6 |
Limitations of cholesterol lowering with PCSK9 inhibitors
|
Thompson, Gilbert |
|
2017 |
5 |
4 |
p. 241-243 3 p. |
artikel |
7 |
Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study
|
Carlsson, Lena M S |
|
2017 |
5 |
4 |
p. 271-279 9 p. |
artikel |
8 |
Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
|
Raal, Frederick J |
|
2017 |
5 |
4 |
p. 280-290 11 p. |
artikel |
9 |
Microvascular complications after metabolic surgery
|
Dimitriadis, George K |
|
2017 |
5 |
4 |
p. 240-241 2 p. |
artikel |
10 |
Oestrogen and anti-androgen therapy for transgender women
|
Tangpricha, Vin |
|
2017 |
5 |
4 |
p. 291-300 10 p. |
artikel |
11 |
Research in brief
|
Kang, Seema |
|
2017 |
5 |
4 |
p. 249- 1 p. |
artikel |
12 |
Semaglutide: a promising new glucagon-like peptide-1 receptor agonist
|
Scheen, André J |
|
2017 |
5 |
4 |
p. 236-238 3 p. |
artikel |
13 |
Sweet success: will sugar taxes improve health?
|
The Lancet Diabetes & Endocrinology, |
|
2017 |
5 |
4 |
p. 235- 1 p. |
artikel |
14 |
Testosterone therapy for transgender men
|
Irwig, Michael S |
|
2017 |
5 |
4 |
p. 301-311 11 p. |
artikel |
15 |
The artificial pancreas—ready for prime time?
|
DeVries, J Hans |
|
2017 |
5 |
4 |
p. 238-239 2 p. |
artikel |
16 |
Transgender hormone therapy: understanding international variation in practice
|
Mamoojee, Yaasir |
|
2017 |
5 |
4 |
p. 243-246 4 p. |
artikel |
17 |
Trans identity: out in the open
|
Morgan, Jules |
|
2017 |
5 |
4 |
p. 250- 1 p. |
artikel |